Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial

Isla S. Mackenzie (Lead / Corresponding author), Christopher J. Hawkey, Ian Ford, Nicola Greenlaw, Filippo Pigazzani, Amy Rogers, Allan D. Struthers, Alan G. Begg, Li Wei, Anthony J. Avery, Jaspal S. Taggar, Andrew Walker, Suzanne L. Duce, Rebecca J. Barr, Jennifer S. Dumbleton, Evelien D. Rooke, Jonathan N. Townend, Lewis D. Ritchie, Thomas M. MacDonald, ALL-HEART study group

Research output: Contribution to journal › Article › peer-review

100 Citations (Scopus)

142 Downloads (Pure)

1 results

Finished
Allopurinol and Cardiovascular Outcomes in Patients with Ischaemic Heart Disease (Joint with Robertson Centre for Biostatistics, University of Nottingham and University College London)
MacDonald, T. (Investigator), Mackenzie, I. (Investigator) & Struthers, A. (Investigator)
1/09/13 → 31/08/22
Project: Research